Marquette Asset Management LLC Invests $77,000 in Adaptimmune Therapeutics plc (NASDAQ:ADAP)
Marquette Asset Management LLC purchased a new position in Adaptimmune Therapeutics plc (NASDAQ:ADAP – Free Report) in the third quarter, Holdings Channel reports. The fund purchased 99,349 shares of the biotechnology company’s stock, valued at approximately $77,000. Other large investors also recently bought and sold shares of the company. Two Sigma Investments LP acquired a […]